Cargando…
Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]
Autor principal: | Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995159/ https://www.ncbi.nlm.nih.gov/pubmed/35418753 http://dx.doi.org/10.2147/IJN.S357154 |
Ejemplares similares
-
Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer
por: Ren, Shuai, et al.
Publicado: (2021) -
Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer [Corrigendum]
Publicado: (2022) -
Glypican-1-antibody-conjugated Gd–Au nanoclusters for FI/MRI dual-modal targeted detection of pancreatic cancer
por: Huang, Xin, et al.
Publicado: (2018) -
Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor
por: Chen, Hetao, et al.
Publicado: (2016) -
Aluminium hydroxide stabilised MnFe(2)O(4) and Fe(3)O(4) nanoparticles as dual-modality contrasts agent for MRI and PET imaging
por: Cui, Xianjin, et al.
Publicado: (2014)